Delivery Order SPE2DB22D1202-SPE2DB23FHUX4
Award Date 7/11/23
Potential Completion Date 7/12/23
Potential Value $7.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,954.47 to AmerisourceBergen Drug Corp for Xultophy 100 Unit-3.6mg/mL pens (3mL quantity) on December 11, 2025, with completion scheduled for December 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $5,793.96 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for XULTOPHY 100 Unit-3.6mg/ml Pen 3ml pharmaceutical product, with completion expected by November 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,409.87 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a injectable diabetes medication. This non-competitive delivery order was awarded on October 21, 2025, with an ultimate completion date of October 22, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal medical supply chain for military and...
- The Defense Logistics Agency awarded a $3,026.12 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for Trulicity 1.5 mg/0.5 mL pen insulin medication. This is a firm fixed price contract with an ultimate completion date of September 2, 2025, and represents a non-competitive award to the established pharmaceutical supplier. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a Delivery Order (DO) valued at $1,120.66 to AmerisourceBergen Drug Corp for LYUMJEV 100 Unit/ML Vial 10ML, a rapid-acting insulin medication used in diabetes treatment. This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of November 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Novoleg 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $2,075.58. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on November 4, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $2,616.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a non-set-aside competitive award with an ultimate completion date of October 29, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,176.72 for Mounjaro 5 mg/0.5 ml pen (tirzepatide injection), a GLP-1 receptor agonist used for diabetes management. This firm fixed-price delivery order, awarded on August 11, 2025, with ultimate completion by August 12, 2025, was competitively awarded with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $2,644.53 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026 that supports global...
- The Defense Logistics Agency awarded a delivery order valued at $1,156.40 to AmerisourceBergen Drug Corp for Insulin Degludec Pen (U-200) 3ML, a diabetes medication delivery system. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and was awarded on August 1, 2025. No set-aside designation was used in this competitive procurement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...